Global Adjuvant Therapy Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: G9BC4EF4F30CEN
QYResearch

Abstracts

This report focuses on the global Adjuvant Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adjuvant Therapy development in North America, Europe and Asia-Pacific.

The key players covered in this study

• Merck
• Bayer
• Johnson & Johnson
• AstraZenca
• Mylan
• AbbVie
• Novartis

Market segment by Type, the product can be split into

• Chemotherapy
• Radiotherapy
• Hormonotherapy
• Others

Market segment by Application, split into

• Hospital
• Medical Institution
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Adjuvant Therapy status, future forecast, growth opportunity, key market and key players.
• To present the Adjuvant Therapy development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Adjuvant Therapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Adjuvant Therapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global Adjuvant Therapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Chemotherapy
  1.4.3 Radiotherapy
  1.4.4 Hormonotherapy
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Adjuvant Therapy Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Medical Institution
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Adjuvant Therapy Industry Impact
  1.6.1 How the Covid-19 is Affecting the Adjuvant Therapy Industry
    1.6.1.1 Adjuvant Therapy Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Adjuvant Therapy Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Adjuvant Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Adjuvant Therapy Market Perspective (2015-2026)
2.2 Adjuvant Therapy Growth Trends by Regions
  2.2.1 Adjuvant Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Adjuvant Therapy Historic Market Share by Regions (2015-2020)
  2.2.3 Adjuvant Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Adjuvant Therapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Adjuvant Therapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Adjuvant Therapy Players by Market Size
  3.1.1 Global Top Adjuvant Therapy Players by Revenue (2015-2020)
  3.1.2 Global Adjuvant Therapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Adjuvant Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Adjuvant Therapy Market Concentration Ratio
  3.2.1 Global Adjuvant Therapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Adjuvant Therapy Revenue in 2019
3.3 Adjuvant Therapy Key Players Head office and Area Served
3.4 Key Players Adjuvant Therapy Product Solution and Service
3.5 Date of Enter into Adjuvant Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Adjuvant Therapy Historic Market Size by Type (2015-2020)
4.2 Global Adjuvant Therapy Forecasted Market Size by Type (2021-2026)

5 ADJUVANT THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Adjuvant Therapy Market Size by Application (2015-2020)
5.2 Global Adjuvant Therapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Adjuvant Therapy Market Size (2015-2020)
6.2 Adjuvant Therapy Key Players in North America (2019-2020)
6.3 North America Adjuvant Therapy Market Size by Type (2015-2020)
6.4 North America Adjuvant Therapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Adjuvant Therapy Market Size (2015-2020)
7.2 Adjuvant Therapy Key Players in Europe (2019-2020)
7.3 Europe Adjuvant Therapy Market Size by Type (2015-2020)
7.4 Europe Adjuvant Therapy Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Adjuvant Therapy Market Size (2015-2020)
8.2 Adjuvant Therapy Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Adjuvant Therapy Market Size by Type (2015-2020)
8.4 Asia-Pacific Adjuvant Therapy Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Merck
  9.1.1 Merck Company Details
  9.1.2 Merck Business Overview and Its Total Revenue
  9.1.3 Merck Adjuvant Therapy Introduction
  9.1.4 Merck Revenue in Adjuvant Therapy Business (2015-2020))
  9.1.5 Merck Recent Development
9.2 Bayer
  9.2.1 Bayer Company Details
  9.2.2 Bayer Business Overview and Its Total Revenue
  9.2.3 Bayer Adjuvant Therapy Introduction
  9.2.4 Bayer Revenue in Adjuvant Therapy Business (2015-2020)
  9.2.5 Bayer Recent Development
9.3 Johnson & Johnson
  9.3.1 Johnson & Johnson Company Details
  9.3.2 Johnson & Johnson Business Overview and Its Total Revenue
  9.3.3 Johnson & Johnson Adjuvant Therapy Introduction
  9.3.4 Johnson & Johnson Revenue in Adjuvant Therapy Business (2015-2020)
  9.3.5 Johnson & Johnson Recent Development
9.4 AstraZenca
  9.4.1 AstraZenca Company Details
  9.4.2 AstraZenca Business Overview and Its Total Revenue
  9.4.3 AstraZenca Adjuvant Therapy Introduction
  9.4.4 AstraZenca Revenue in Adjuvant Therapy Business (2015-2020)
  9.4.5 AstraZenca Recent Development
9.5 Mylan
  9.5.1 Mylan Company Details
  9.5.2 Mylan Business Overview and Its Total Revenue
  9.5.3 Mylan Adjuvant Therapy Introduction
  9.5.4 Mylan Revenue in Adjuvant Therapy Business (2015-2020)
  9.5.5 Mylan Recent Development
9.6 AbbVie
  9.6.1 AbbVie Company Details
  9.6.2 AbbVie Business Overview and Its Total Revenue
  9.6.3 AbbVie Adjuvant Therapy Introduction
  9.6.4 AbbVie Revenue in Adjuvant Therapy Business (2015-2020)
  9.6.5 AbbVie Recent Development
9.7 Novartis
  9.7.1 Novartis Company Details
  9.7.2 Novartis Business Overview and Its Total Revenue
  9.7.3 Novartis Adjuvant Therapy Introduction
  9.7.4 Novartis Revenue in Adjuvant Therapy Business (2015-2020)
  9.7.5 Novartis Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Adjuvant Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Adjuvant Therapy Revenue
Table 3. Ranking of Global Top Adjuvant Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Adjuvant Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Radiotherapy
Table 7. Key Players of Hormonotherapy
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Adjuvant Therapy Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Adjuvant Therapy Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Adjuvant Therapy Players to Combat Covid-19 Impact
Table 14. Global Adjuvant Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Adjuvant Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Adjuvant Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Adjuvant Therapy Market Share by Regions (2015-2020)
Table 18. Global Adjuvant Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Adjuvant Therapy Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Adjuvant Therapy Market Growth Strategy
Table 24. Main Points Interviewed from Key Adjuvant Therapy Players
Table 25. Global Adjuvant Therapy Revenue by Players (2015-2020) (Million US$)
Table 26. Global Adjuvant Therapy Market Share by Players (2015-2020)
Table 27. Global Top Adjuvant Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adjuvant Therapy as of 2019)
Table 28. Global Adjuvant Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Adjuvant Therapy Product Solution and Service
Table 31. Date of Enter into Adjuvant Therapy Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Adjuvant Therapy Market Size by Type (2015-2020) (Million US$)
Table 34. Global Adjuvant Therapy Market Size Share by Type (2015-2020)
Table 35. Global Adjuvant Therapy Revenue Market Share by Type (2021-2026)
Table 36. Global Adjuvant Therapy Market Size Share by Application (2015-2020)
Table 37. Global Adjuvant Therapy Market Size by Application (2015-2020) (Million US$)
Table 38. Global Adjuvant Therapy Market Size Share by Application (2021-2026)
Table 39. North America Key Players Adjuvant Therapy Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Adjuvant Therapy Market Share (2019-2020)
Table 41. North America Adjuvant Therapy Market Size by Type (2015-2020) (Million US$)
Table 42. North America Adjuvant Therapy Market Share by Type (2015-2020)
Table 43. North America Adjuvant Therapy Market Size by Application (2015-2020) (Million US$)
Table 44. North America Adjuvant Therapy Market Share by Application (2015-2020)
Table 45. Europe Key Players Adjuvant Therapy Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Adjuvant Therapy Market Share (2019-2020)
Table 47. Europe Adjuvant Therapy Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Adjuvant Therapy Market Share by Type (2015-2020)
Table 49. Europe Adjuvant Therapy Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Adjuvant Therapy Market Share by Application (2015-2020)
Table 51. Asia-Pacific Key Players Adjuvant Therapy Revenue (2019-2020) (Million US$)
Table 52. Asia-Pacific Key Players Adjuvant Therapy Market Share (2019-2020)
Table 53. Asia-Pacific Adjuvant Therapy Market Size by Type (2015-2020) (Million US$)
Table 54. Asia-Pacific Adjuvant Therapy Market Share by Type (2015-2020)
Table 55. Asia-Pacific Adjuvant Therapy Market Size by Application (2015-2020) (Million US$)
Table 56. Asia-Pacific Adjuvant Therapy Market Share by Application (2015-2020)
Table 57. Merck Company Details
Table 58. Merck Business Overview
Table 59. Merck Product
Table 60. Merck Revenue in Adjuvant Therapy Business (2015-2020) (Million US$)
Table 61. Merck Recent Development
Table 62. Bayer Company Details
Table 63. Bayer Business Overview
Table 64. Bayer Product
Table 65. Bayer Revenue in Adjuvant Therapy Business (2015-2020) (Million US$)
Table 66. Bayer Recent Development
Table 67. Johnson & Johnson Company Details
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Product
Table 70. Johnson & Johnson Revenue in Adjuvant Therapy Business (2015-2020) (Million US$)
Table 71. Johnson & Johnson Recent Development
Table 72. AstraZenca Company Details
Table 73. AstraZenca Business Overview
Table 74. AstraZenca Product
Table 75. AstraZenca Revenue in Adjuvant Therapy Business (2015-2020) (Million US$)
Table 76. AstraZenca Recent Development
Table 77. Mylan Company Details
Table 78. Mylan Business Overview
Table 79. Mylan Product
Table 80. Mylan Revenue in Adjuvant Therapy Business (2015-2020) (Million US$)
Table 81. Mylan Recent Development
Table 82. AbbVie Company Details
Table 83. AbbVie Business Overview
Table 84. AbbVie Product
Table 85. AbbVie Revenue in Adjuvant Therapy Business (2015-2020) (Million US$)
Table 86. AbbVie Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Product
Table 90. Novartis Revenue in Adjuvant Therapy Business (2015-2020) (Million US$)
Table 91. Novartis Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Adjuvant Therapy Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Hormonotherapy Features
Figure 5. Others Features
Figure 6. Global Adjuvant Therapy Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Medical Institution Case Studies
Figure 9. Others Case Studies
Figure 10. Adjuvant Therapy Report Years Considered
Figure 11. Global Adjuvant Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Adjuvant Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Adjuvant Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Adjuvant Therapy Market Share by Players in 2019
Figure 16. Global Top Adjuvant Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adjuvant Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Adjuvant Therapy Revenue in 2019
Figure 18. North America Adjuvant Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Adjuvant Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Asia-Pacific Adjuvant Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Merck Revenue Growth Rate in Adjuvant Therapy Business (2015-2020)
Figure 23. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Bayer Revenue Growth Rate in Adjuvant Therapy Business (2015-2020)
Figure 25. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Johnson & Johnson Revenue Growth Rate in Adjuvant Therapy Business (2015-2020)
Figure 27. AstraZenca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. AstraZenca Revenue Growth Rate in Adjuvant Therapy Business (2015-2020)
Figure 29. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Mylan Revenue Growth Rate in Adjuvant Therapy Business (2015-2020)
Figure 31. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. AbbVie Revenue Growth Rate in Adjuvant Therapy Business (2015-2020)
Figure 33. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis Revenue Growth Rate in Adjuvant Therapy Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed